Related Experiment Video

Updated: Jul 5, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2

Toshihiro Hashizume1, Takayuki Fukuda, Tadahiro Nagaoka

  • 1Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-Naka, Okayama 700-8530, Japan.

Cell Biology International
|April 30, 2008
PubMed

Insights

Ligand-dependent ErbB2 internalization, crucial for cancer therapy, differs between cell types. EC-eGFP peptide revealed ErbB2 internalization in SKOv3 cells but not SKBr3 cells, suggesting distinct cellular mechanisms.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • ErbB2 receptor tyrosine kinase is overexpressed in breast and ovarian cancers.
  • Targeted therapies using antibodies and small molecule inhibitors are used for ErbB2-overexpressing cancers.
  • Ligand-induced internalization and downregulation of ErbB2 are potentially vital for therapeutic efficacy, but this process is not well understood.

Purpose of the Study:

  • To investigate the ligand-dependent internalization of ErbB2 in cancer cell lines.
  • To characterize the mechanisms of ErbB2 internalization in ErbB2-overexpressing cells.

Main Methods:

  • Utilized an EC-1 peptide fused to eGFP (EC-eGFP) that specifically binds ErbB2.
  • Studied ErbB2 internalization in SKBr3 and SKOv3 cell lines, both known for ErbB2 overexpression.
  • Analyzed ErbB2 endosomal accumulation and colocalization with transferrin to infer endocytosis pathways.

Main Results:

  • ErbB2 internalization was observed in SKOv3 cells upon treatment with EC-eGFP.
  • EC-eGFP-dependent accumulation of endosomal ErbB2 colocalized with transferrin, indicating clathrin-coated pit-mediated endocytosis.
  • No significant internalization of ErbB2 was detected in SKBr3 cells under the same conditions.

Conclusions:

  • Two distinct, cell-type-dependent mechanisms govern ErbB2 internalization.
  • The findings highlight the heterogeneity in ErbB2 trafficking pathways, impacting targeted therapy strategies.
  • Further research into these mechanisms could optimize therapeutic interventions for ErbB2-driven cancers.

More Related Videos

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells12:38

Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells

Published on: November 6, 2021

Related Concept Videos

Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Receptor-Mediated Endocytosis01:20

Receptor-Mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
ER Retrieval Pathway01:45

ER Retrieval Pathway

In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...